Subject (74)Biopharma deal contingency planning and Canadian biotechs to watch in 2023
Preheader (150)View this email in your browser INDUSTRY PERSPECTIVES Contingencies for Biopharma, Medtech Deal Planning in a Down Market The Life Science Report, Pod
TypographyColorsText AnalysisBody Words1215
Subject Words11
Body Emojis1
Media AnalysisText Links7
Total Links7
Images3
Technical MetricsPerformancePixel Length, px2159 px
X-Spam Score-5.0
Preheader OptimizedNo
TimingDay of WeekFriday
TimeEvening